Export

EN
FR
Levofloxacin
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.5. Antituberculosis medicines
ATC codes: J01MA12
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis ICD11 code: ML32.00
INN
Levofloxacin
Medicine type
Chemical agent
Antibiotic groups
WATCH
List type
Core (EML)
(EMLc)
Additional notes
Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB contol.
Formulations
Oral > Solid > dispersible tablet: 100 mg (EMLc)
Oral > Solid > tablet: 250 mg ; 500 mg ; 750 mg (EML)
EML status history
First added in 1999 (TRS 895)
Changed in 2003 (TRS 920)
Changed in 2011 (TRS 965)
Changed in 2013 (TRS 985)
Changed in 2017 (TRS 1006)
Changed in 2019 (TRS 1021)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Levofloxacin
DrugBank
Levofloxacin
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the transfer of listings for medicines for multi-drug resistant tuberculosis from the complementary to the core list of the EML and EMLc.